期刊文献+

肿瘤M2型丙酮酸激酶在非小细胞肺癌诊断中的临床价值 被引量:2

原文传递
导出
摘要 非小细胞肺癌(NSCLC)的辅助诊断和监测常用的肿瘤标志为癌胚抗原(CEA)和细胞角蛋白片段19(CYFRA21-1)。近几年研究发现,肿瘤M2型丙酮酸激酶(M2-PK)在肿瘤患者外周血中的浓度明显升高,可用于肿瘤的早期诊断、预后判断及疗效监测。本研究通过检测M2-PK在肺癌和肺良性疾病患者血浆中的水平变化,同时与NSCLC传统CEA和CYFRA21-1比较,以评价其在诊断NSCLC中的价值。
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2008年第5期555-556,共2页 Chinese Journal of Laboratory Medicine
基金 江苏省常州市科技计划资助项目(CS2006220)
  • 相关文献

参考文献3

二级参考文献19

  • 1Roigas J, Schulze G, Raytarowski S, et al. Tumor M2 pyruvate kinase in renal cell carcinoma. Studies of plasma in patients. Urologe A, 2000, 39(6): 554-556.
  • 2Kim CW, Kim JI, Park SH, et al. Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer. Korean J Gastroenterol, 2003, 42(5): 387-393.
  • 3Mazurek S, Zwerschke W, Jansen-Durr P, et al. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene, 2001, 20(47): 6891-6898.
  • 4Schneider J, Neu K, Velcovsky HG, et al. Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study. Cancer Lett, 2003, 193(1): 91-98.
  • 5Kaura B, Bagga R, Patel FD. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma. J Obstet Gynaecol Res, 2004, 30(3): 193-196.
  • 6Roigas J, Deger S, Schroeder J, et al. Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma. Urol Res, 2003, 31(6): 358-362.
  • 7Luftner D, Mazurek S, Henschke P, et al. Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer. Anticancer Res, 2003, 23(2A): 991-997.
  • 8Hegele A, Varga Z, Kosche B, et al. Pyruvate kinase type tumor M2 in urological malignancies. Urol Int, 2003, 70(1): 55-58.
  • 9Oremek GM, Muller R, Sapoutzis N, et al. Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases. Anticancer Res, 2003, 23(2A): 1131-1134.
  • 10Oremek GM, Gerstmeier F, Sauer-Eppel H, et al. Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK). Anticancer Res, 2003, 23(2A): 1127-1130.

共引文献38

同被引文献47

  • 1陈香丽,陈小燕.血清肿瘤标记物在肺癌诊断中的意义[J].临床肺科杂志,2004,9(6):590-592. 被引量:26
  • 2李湘荣,戴小平.血清CEA与CYFRA21-1检测对肺癌诊断价值的探讨[J].中国血液流变学杂志,2005,15(2):278-279. 被引量:10
  • 3李红,万自芬.肿瘤标志物CEA、CYFRA21-1联检在非小细胞肺癌中的诊断价值[J].放射免疫学杂志,2006,19(5):432-433. 被引量:20
  • 4Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127 (12) : 2893-2917.
  • 5Sriram KB,Larsen JE, Yang IA, et al. Genomic medicine in non- small cell lung cancer : paving the path to personalised care[J]. Re- spirology,2011,16(2) :257-263.
  • 6Han KQ,Huang G,Gao CF,et al. Identification of lung cancer pa- tients by serum protein profiling using surface-enhanced laser de- sorption/ionization time-of-flight mass spectrometry[J].Am J Clin Oneol,2008,31(2) :133-139.
  • 7Koga H,Eguehi K,Shinkai T,et al. Preliminary evaluation of the new tumor marker,CYFRA 21-1, in lung cancer patients[J]. Jpn J Clin Oneo1,1994,2:(5) :263-268.
  • 8Bitterlich N, Muley T, Schneider J. Centre-independent detection of non-small cell lung cancer (NSCLC) by means of classification with receiver operating characteristic (ROC)-based data transfor- mation[J]. Anticancer Res,2010,30(5) :1661-1665.
  • 9Ebert W, Dienemann H, Fateh-Moghadam A, et al. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multieentre study[J]. Eur J Clin Chem Clin Biochem,1994,32(3),189-199.
  • 10Molina R,Auge JM,Escudero JM,et al. Mucins CA 125,CA 19. 9,CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE[J]. Tumour Biol,2008,29(6) :371-a80.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部